COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence.

COVID-19 / complications Carboxymethylcellulose Sodium / analogs & derivatives Cytokine Release Syndrome / etiology Humans Immunization, Passive Interferon Inducers / therapeutic use Mucocutaneous Lymph Node Syndrome / etiology Physical Distancing Poly I-C / therapeutic use Polylysine / analogs & derivatives Practice Guidelines as Topic RNA, Double-Stranded / drug effects RNA, Viral / drug effects Recurrence SARS-CoV-2 / classification Secondary Prevention COVID-19 Drug Treatment COVID-19 Serotherapy

Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 27 10 2020
medline: 18 2 2021
entrez: 26 10 2020
Statut: ppublish

Résumé

The world is now entering its 9

Identifiants

DOI: 10.23736/S0026-4806.20.07054-8 PMID: 33104300
pubmed: 33104300
pii: S0026-4806.20.07054-8
doi: 10.23736/S0026-4806.20.07054-8
doi:

Substances chimiques

Interferon Inducers 0
RNA, Double-Stranded 0
RNA, Viral 0
Polylysine 25104-18-1
poly ICLC 7KYP9TKT70
Carboxymethylcellulose Sodium K679OBS311
Poly I-C O84C90HH2L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

144-152

Auteurs

Giovanni C Actis (GC)

Medical Center S.a.s., Turin, Italy - actis_g@libero.it.

Davide G Ribaldone (DG)

Department of Medical Sciences, University of Turin, Turin, Italy.

Sharmila Fagoonee (S)

Institute for Biostructure and Bioimaging, National Research Council, Molecular Biotechnology Center, Turin, Italy.

Rinaldo Pellicano (R)

Unit of Gastroenterology, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Glucides › Polyosides › Glucanes › Méthylcellulose › Carboxyméthylcellulose de sodium › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Choc › Syndrome de réponse inflammatoire généralisée › Syndrome de libération de cytokines › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunisation passive › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Inducteurs de l'interféron › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Dermatoses vasculaires › Maladie de Kawasaki › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Contrôle des maladies transmissibles › Distanciation physique › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Polynucléotides › Polyribonucléotides › Poly I › Poly I-C › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Polylysine › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Conformation d'acide nucléique › ARN double brin › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN viral › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Récidive › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention secondaire › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitements médicamenteux de la COVID-19 › COVID-19: a user's guide, status of the art...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunisation passive › Transfert adoptif › Sérothérapie COVID-19 › COVID-19: a user's guide, status of the art...